Home » Healthcare » Human Chorionic Gonadotropin Market

Human Chorionic Gonadotropin Market By Type (Recombinant Human Chorionic Gonadotropin, Urinary Human Chorionic Gonadotropin); By Application (Female Infertility Treatment, Male Infertility Treatment, Ovulation Disorders, Cryptorchidism, Others); By Route of Administration (Intramuscular Injection, Subcutaneous Injection); By End-User (Hospitals, Fertility Clinics, Research Institutes, Others); By Pregnancy Test Kits (Urine-based Pregnancy Test Kits, Blood-based Pregnancy Test Kits); By Dosage Form (Powder for Injection, Liquid for Injection); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Published: | Report ID: 7343 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Human Chorionic Gonadotropin Market Size 2023  USD 1151.5 Million
Human Chorionic Gonadotropin Market, CAGR  8.10%
Human Chorionic Gonadotropin Market Size 2032  USD 2321.11 Million

Market Insights

  • The global Human Chorionic Gonadotropin (hCG) market size was valued at USD 1151.5 Million in 2023 and is projected to reach USD 2321.11 Million by 2032, exhibiting a significant Compound Annual Growth Rate (CAGR) of 8.10% during the forecast period from 2024 to 2032.
  • Recombinant Human Chorionic Gonadotropin (r-hCG) holds the largest market share, accounting for about 60-65% of the hCG market. This dominance is attributed to greater purity, lower allergy risks, and wider clinical applications. Growth drivers include enhanced production, novel formulations, expanding use in male infertility and Assisted Reproductive Technologies (ART), and non-reproductive research.
  • Powder for Injection is the dominant dosage form in the hCG market, holding a larger market share of 60-70% due to its established presence and lower cost. Liquid for Injection is a growing share at 30-40%, driven by convenience and improved patient experience.
  • Female Infertility Treatment is the leading application in the hCG market, holding the largest share of about 35-40%. This includes the rising prevalence of female infertility issues such as ovulation disorders and Polycystic Ovary Syndrome (PCOS), the increasing demand for ART like In Vitro Fertilization (IVF), and growing awareness and acceptance of infertility treatments.
  • Hospitals hold the largest share in the hCG market by end-user, contributing over 25%. This is due to their extensive infrastructure, a broad range of specialists, and increasing adoption of minimally invasive procedures. Endocrinologists, gynecologists, and urologists utilize hCG for various indications, and advancements in technology drive hCG use in laparoscopic surgeries.
  • North America dominates the global Human Chorionic Gonadotropin (hCG) market with a share of 40-45%. This dominance is driven by high infertility rates, advanced healthcare infrastructure, rising disposable income, and increasing awareness of ART. The region’s large share is also attributed to the presence of prominent players and developed healthcare systems in the US and Canada.
  • Europe holds the second-largest market share of the hCG market, with a share of 30-35%. Influenced by strict regulations and the rise of biosimilar hCG, the region’s advanced healthcare infrastructure and high infertility rates continue to drive market growth.

Human Chorionic Gonadotropin Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Market Definition

Human Chorionic Gonadotropin (hCG) is a hormone found in the blood and urine of pregnant individuals. It is produced by the placenta after implantation. This hormone is commonly used as a marker in home pregnancy tests. hCG levels are also monitored during early pregnancy to ensure the health of the pregnancy and the developing fetus. Additionally, hCG is used in assisted reproduction techniques, as it plays a crucial role in the implantation of the embryo and the maintenance of the early stages of pregnancy. The rise of hCG in early pregnancy has been associated with the mode of conception and birth weight. hCG is a glycoprotein hormone comprising two subunits, alpha and beta, and its various forms have wide-ranging functions and clinical applications.

Market Overview

The global Human Chorionic Gonadotropin (hCG) market has witnessed significant growth in recent years and is poised to demonstrate a noteworthy Compound Annual Growth Rate (CAGR) of 8.10% between 2024 and 2032. With a market value of USD 1151.5 million in 2023, it is anticipated to reach USD 2321.11 million by 2032.

A key driver propelling the growth of the hCG market is the increasing recognition of hCG technology as a crucial element in reproductive and fertility-related applications. This surge in acceptance is attributed to hCG’s vital role in home pregnancy tests, female and male infertility treatments, and assisted reproductive technologies (ART), showcasing its significance in ensuring the health of pregnancy and supporting fertility.

Moreover, the hCG market is actively driven by its ability to address the challenges posed by infertility and reproductive health issues, providing solutions for hormonal support in various clinical scenarios. The market is expected to witness substantial growth during the forecast period, driven by the expanding applications of hCG in both traditional and innovative reproductive healthcare practices.

In addition to its application in conventional fertility treatments, the hCG market is finding new opportunities in emerging reproductive technologies, responding to the demand for advanced interventions, personalized medicine, and improved outcomes. The rising collaboration between medical research institutions and industry players is fostering the development of new technologies and applications in the hCG market, contributing to its continuous growth and evolution.

Segmentation by Type

  • Recombinant Human Chorionic Gonadotropin (r-hCG) hold 60-65% market share due to greater purity, lower allergy risks, and wider clinical applications. Growth drivers include enhanced production, novel formulations, expanding use in male infertility and ART, and non-reproductive research.
  • Urinary Human Chorionic Gonadotropin (u-hCG) has historically been used due to its lower cost, but it’s facing a decline in market share due to safety concerns and limited applications. It’s mainly used in veterinary applications and pregnancy testing kits, with potential niche growth in resource-limited settings due to its affordability.

Segmentation by Application

  • The female infertility treatment segment holds the largest share of about 35-40% of the market. This includes the rising prevalence of female infertility issues such as ovulation disorders and Polycystic Ovary Syndrome (PCOS), the increasing demand for assisted reproductive technologies (ART) like In Vitro Fertilization (IVF), and growing awareness and acceptance of infertility treatments, especially in developed regions.
  • The male infertility treatment market is expected to witness the highest CAGR during the forecast period. This is due to rising infertility rates among men caused by lifestyle factors and environmental influences, growing adoption of hCG therapy for stimulating sperm production in cases of hypogonadism and other conditions, and advancements in diagnostic techniques leading to earlier identification and treatment of male infertility.

Segmentation by Route of Administration

  • Intramuscular injection is the dominant segment in the hCG market due to tradition, faster absorption, and cost-effectiveness. Healthcare providers are familiar with the protocols, and it leads to faster absorption, making it a preferred choice in certain clinical situations. Additionally, intramuscular injection may be seen as more cost-effective in some healthcare settings.
  • The subcutaneous injection segment is expected to have the highest CAGR in the coming years due to convenience, patient preference, and advances in injection devices. Patients find subcutaneous injections less painful and more convenient than intramuscular injections, while healthcare providers appreciate the ease of use and smaller size of modern subcutaneous injection devices.

Segmentation by End-User

  • Hospitals hold largest share ofovber 25% of the hCG market due to their extensive infrastructure, broad range of specialists, and increasing adoption of minimally invasive procedures. Endocrinologists, gynecologists, and urologists utilize hCG for various indications, and advancements in technology drive hCG use in laparoscopic surgeries.
  • Fertility clinics are experiencing significant growth due to rising infertility rates, growing awareness of fertility preservation options, and expansion of the fertility tourism industry. hCG plays a crucial role in assisted reproductive technologies (ARTs), such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). The increase in demand for these treatments drives the market for hCG.

Segmentation by Pregnancy Test Kits

  • Urine-based tests currently hold the largest share due to their affordability, ease of use, and wide availability.
  • Blood-based tests are expected to exhibit the highest CAGR due to their higher accuracy, ability to detect pregnancy earlier, and quantitative measurement capabilities, which aid in monitoring ovarian function, fertility issues, and multiple pregnancies. These advantages make them a preferred choice for clinicians and researchers.

Segmentation by Dosage Form

  • Powder for Injection holds the larger market share (60-70%) due to its established presence and lower cost.
  • Liquid for Injection growing share (30-40%), driven by convenience and improved patient experience.

Segmentation by Region

  • North America dominates the hCG market with a share of 40-45%, driven by high infertility rates, advanced healthcare infrastructure, rising disposable income, and increasing awareness of assisted reproductive technologies (ART). The region’s large share is also attributed to the presence of prominent players and developed healthcare systems in the US and Canada.
  • Europe hold second latgest market share of hCG market is 30-35%, influenced by strict regulations and the rise of biosimilar hCG. Morever,  the region’s advanced healthcare infrastructure and high infertility rates continue to drive market growth.
  • Asia Pacific will experience the fastest CAGR in the hCG market from 2024-2032, driven by a large and growing population, increasing healthcare expenditure, rising awareness about fertility treatments, and expanding access to healthcare in developing countries. China, India, and Japan are key contributors to the regional market growth.

Factors like increasing government support for infertility treatments, rising disposable income, and advancements in hCG technology will drive market growth in these regions.

North America dominates the global human chorionic gonadotropin (hCG) market due to high infertility rates, advanced healthcare infrastructure, and a strong focus on research and development. The US has a large and growing market for hCG, driven by factors such as PCOS, obesity, and smoking, which contribute to infertility. The presence of major pharmaceutical companies and fertility clinics in the region further boosts market growth. There is an increasing trend towards using hCG in fertility treatments like IVF and ICSI, contributing to the growth of the hCG market in North America. According to the CDC, in 2022, 13.4% of women aged 15-49 in the US had impaired fecundity, with higher rates among married women and women with no children. 8.5% of married women aged 15-49 were infertile, and 12.2% of women aged 15-49 had ever used infertility services.

Europe holds the second largest market share of human chorionic gonadotropin (hCG) globally. The region’s well-established healthcare system, high infertility rates, and increasing awareness about fertility treatments contribute to the market’s growth. Germany, France, and the UK are the top three countries in terms of hCG market share in Europe. According to a report by the European Society of Human Reproduction and Embryology (ESHRE) in 2020, the number of women undergoing hCG treatment in Europe increased by over 15% between 2017 and 2020. This upsurge is largely due to the growing awareness about the benefits of hCG treatment and the increasing availability of affordable hCG products in the region.

Key Highlights of the Report

The global Human Chorionic Gonadotropin (hCG) market is comprehensively segmented based on type, dosage form, application, route of administration, end-user, pregnancy test kits, and region. Recombinant Human Chorionic Gonadotropin (r-hCG) holds the largest market share, driven by its greater purity, lower allergy risks, and wider clinical applications. Powder for Injection constitutes the larger market share in dosage form, owing to its established presence and lower cost.

Female infertility treatment is the dominant application, accounting for the largest share due to the rising prevalence of ovulation disorders and the increasing demand for assisted reproductive technologies (ART). Intramuscular injection is the dominant route of administration, driven by tradition, faster absorption, and cost-effectiveness. Hospitals are the leading end-users, with over 25% market share, utilizing hCG for various indications, including laparoscopic surgeries.

Urine-based pregnancy test kits currently hold the largest share, offering affordability, ease of use, and wide availability. Powder for Injection is the predominant dosage form, holding a larger market share of 60-70%, while Liquid for Injection is gaining popularity due to convenience and improved patient experience.

North America dominates the hCG market with a share of 40-45%, driven by high infertility rates, advanced healthcare infrastructure, rising disposable income, and increasing awareness of ART. Europe holds the second-largest market share of 30-35%, influenced by strict regulations and the rise of biosimilar hCG. Asia Pacific is expected to experience the fastest CAGR from 2024-2032, driven by a large and growing population, increasing healthcare expenditure, rising awareness about fertility treatments, and expanding access to healthcare in developing countries. The primary drivers for the hCG market include increasing infertility rates, the rise of female-related infertility issues, availability of recombinant hCGs, and the growing prevalence of hypogonadism in males.

What Are The Main Drivers Of The Global Human Chorionic Gonadotropin Market?

The global human chorionic gonadotropin (HCG) market is driven by increasing infertility rates, rise in female-related infertility issues, availability of recombinant HCGs, and growing prevalence of hypogonadism in males.

What Are The Major Challenges Faced By The Global Human Chorionic Gonadotropin Market?

The global human chorionic gonadotropin (HCG) market faces several challenges, including the availability of alternatives, regulatory warnings, and the impact of COVID-19. These factors are expected to hinder market growth over the forecast period. Additionally, the presence of substitutes is likely to pose a challenge to the market’s expansion.

What Are The Growth Opportunities In The Global Human Chorionic Gonadotropin Market?

The global human chorionic gonadotropin (HCG) market is expected to witness growth opportunities in the coming years, driven by increasing demand for fertility treatments, rising prevalence of infertility, and advancements in reproductive technologies. Emerging markets, such as China and India, are expected to drive market growth due to increasing disposable income and growing awareness about fertility treatments. Furthermore, the development of new drugs and therapies, such as personalized medicine and gene editing techniques, are expected to create new opportunities for market players.

Market Drivers

The global Human Chorionic Gonadotropin market is driven by several factors. The following are the key drivers of the global Human Chorionic Gonadotropin market:

Increasing Infertility Rates

The increasing prevalence of infertility is a significant driver for the human chorionic gonadotropin (HCG) market. According to the American Society for Reproductive Medicine (ASRM), approximately 1 in 8 couples in the United States struggle with infertility. Large numbers of people are affected by infertility in their lifetime, according to a new report published today WHO. Around 17.5% of the adult population – roughly 1 in 6 worldwide – experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need. This rising prevalence is primarily due to lifestyle factors such as delayed marriage and childbearing, increased stress levels, and poor dietary habits. Moreover, the prevalence of obesity and related health conditions, such as polycystic ovary syndrome (PCOS), has also contributed to the growing demand for HCG therapy.

Market Restraints

The global Human Chorionic Gonadotropin market faces some challenges that may hinder its growth. These include the following:

Regulatory Warnings

Regulatory warnings issued by authorities, such as the FDA, about the risks of using human chorionic gonadotropin (HCG) may limit the market’s growth in the coming years. For example, in 2020, the FDA issued a warning letter to healthcare providers regarding the potential risks associated with the use of HCG for weight loss, citing reports of serious adverse events, including blood clots, stroke, and death. This warning has led to increased scrutiny of HCG products and may deter some consumers from using them, thereby limiting market growth.

Opportunities

The global Human Chorionic Gonadotropin market offers significant growth opportunities. These include the following:

Advancements in Reproductive Technologies

Advancements in reproductive technologies have played a crucial role in driving the growth of the human chorionic gonadotropin (HCG) market. The development of assisted reproductive technologies (ART) such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) has increased the demand for HCG, as it is often used in combination with these treatments to enhance fertility outcomes. Additionally, advances in genetic testing and screening have enabled better identification and selection of embryos, further boosting the demand for HCG. For instance, with the introduction of at-home fertility tests and telemedicine, more people have access to fertility services, and the cost of treatments has become more manageable

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global Human Chorionic Gonadotropin market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Sanzyme
  • Merck & Co. Inc.
  • Ferring BV
  • Fresenius Kabi AG
  • Sun Pharmaceutical Industries Ltd
  • Medix Biochemica (Lee BioSolutions Inc.)
  • Scripps Laboratories
  • Prospec-Tany Technogene Ltd
  • Biocare Medical LLC
  • Kamiya Biomedical Company
  • Others

These organizations prioritize product innovation, distribution channel expansion, and mergers and acquisitions to stay competitive.

The global Human Chorionic Gonadotropin market’s key players continually seek to stay ahead by offering new products and developments.

In December 2023, Orchid, a reproductive technology startup, launched a whole genome sequencing test for embryos to identify genetic defects before an IVF pregnancy begins. The test can detect birth defects, neurodevelopmental disorders, chromosomal abnormalities, and pediatric and adult-onset cancers. It aims to help couples undergoing IVF make informed decisions about their reproductive health.

In October 2022, Inception Fertility collaborated with top tech firms on cutting-edge research to revolutionize reproductive medicine, enhancing patient care and pregnancy success.

In January 2022, J. B. Chemicals & Pharmaceuticals Limited acquired Brands and Related Assets from Sanzyme Limited for around USD 520 billion. The transaction excludes taxes, stamp duty, and working capital and will be paid in cash.

Summary of Key Findings

  • The Human Chorionic Gonadotropin (hCG) market is experiencing increased demand driven by its crucial role in reproductive and fertility-related applications, including home pregnancy tests, female and male infertility treatments, and assisted reproductive technologies (ART).
  • The market is comprehensively segmented based on type, dosage form, application, route of administration, end-user, pregnancy test kits, and region.
  • Recombinant Human Chorionic Gonadotropin (r-hCG) is the most popular type, with Powder for Injection dominating the dosage form. Female infertility treatment is the leading application, and hospitals are the primary end-users.
  • North America dominates the market, followed by Europe and the Asia Pacific. The Asia Pacific region is expected to experience the fastest CAGR from 2024-2032, driven by a large and growing population, increasing healthcare expenditure, and rising awareness about fertility treatments.
  • Key players in the market include Sanzyme, Merck & Co. Inc., Ferring BV, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd, Medix Biochemica, Scripps Laboratories, Prospec-Tany Technogene Ltd, Biocare Medical LLC, Kamiya Biomedical Company, and others.

Future Outlook

  • The Human Chorionic Gonadotropin (hCG) market has a positive outlook, with substantial growth potential, especially in the Asia Pacific region.
  • Government and industry support for infertility treatments, rising disposable income, and advancements in hCG technology are significant drivers for market expansion.
  • During the forecast period, the increasing demand for fertility treatments, rising prevalence of infertility, and advancements in reproductive technologies are expected to drive market growth. Key firms should focus on product innovation, expanding market reach, and maintaining competitive pricing to stay ahead in the competitive landscape of the hCG market.

How CXOs Can Benefit from the Credence Research Human Chorionic Gonadotropin Market Report

The Credence Research Human Chorionic Gonadotropin Market Report provides CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast: The report provides detailed estimates of the global Human Chorionic Gonadotropin market size, segmented by fiber type, network type, application, and region. It also includes forecasts for the market through 2032, based on key trends and drivers.
  • Market segmentation: The report segments the Human Chorionic Gonadotropin market by fiber type, network type, application, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive landscape: The report profiles the key players in the Human Chorionic Gonadotropin market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the Human Chorionic Gonadotropin market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Human Chorionic Gonadotropin Market Report to:

  • Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the Human Chorionic Gonadotropin market. For example, the report identifies the growing demand for Human Chorionic Gonadotropin from cloud computing providers and telecom companies as a key opportunity.
  • Make informed investment decisions: The report can help CXOs to make informed investment decisions about Human Chorionic Gonadotropin. For example, the report provides insights into the key factors to consider when evaluating dark fiber providers and selecting dark fiber solutions.
  • Develop competitive strategies: The report can help CXOs to develop competitive strategies for their Human Chorionic Gonadotropin businesses. For example, the report identifies the key strategies that dark fiber providers are using to differentiate themselves from their competitors.
  • Track market developments: The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the Human Chorionic Gonadotropin market.

Overall, the Credence Research Human Chorionic Gonadotropin Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

  • By Type:
    • Recombinant Human Chorionic Gonadotropin (r-hCG)
    • Urinary Human Chorionic Gonadotropin (u-hCG)
  • By Application:
    • Female Infertility Treatment
    • Male Infertility Treatment
    • Ovulation Disorders
    • Cryptorchidism
    • Others
  • By Route of Administration:
    • Intramuscular Injection
    • Subcutaneous Injection
  • By End-User:
    • Hospitals
    • Fertility Clinics
    • Research Institutes
    • Others
  • By Pregnancy Test Kits:
    • Urine-based Pregnancy Test Kits
    • Blood-based Pregnancy Test Kits
  • By Dosage Form:
    • Powder for Injection
    • Liquid for Injection
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Human Chorionic Gonadotropin Market
2.1.1. Global Human Chorionic Gonadotropin Market, By Type
2.1.2. Global Human Chorionic Gonadotropin Market, By Application
2.1.3. Global Human Chorionic Gonadotropin Market, By Route of Administration
2.1.4. Global Human Chorionic Gonadotropin Market, By End-User
2.1.5. Global Human Chorionic Gonadotropin Market, By Pregnancy Test Kits
2.1.6. Global Human Chorionic Gonadotropin Market, By Dosage Form
2.1.7. Global Human Chorionic Gonadotropin Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Human Chorionic Gonadotropin Market Value, 2019-2032, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Wired Drivers
3.2.2. Human Chorionic Gonadotropin Market Restraints
3.2.3. Human Chorionic Gonadotropin Market Opportunities
3.2.4. Major Human Chorionic Gonadotropin Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Application
3.5.3. Route of Administration
3.5.4. End-User
3.5.5. Pregnancy Test Kits
3.5.6. Dosage Form
3.5.7. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2023
4.1.1. Global Human Chorionic Gonadotropin Market: Company Market Share, Value 2023
4.1.2. Global Human Chorionic Gonadotropin Market: Top 6 Company Market Share, Value 2023
4.1.3. Global Human Chorionic Gonadotropin Market: Top 3 Company Market Share, Value 2023
4.2. Global Human Chorionic Gonadotropin Market: Company Revenue Share Analysis, 2023
4.3. Company Assessment Metrics, 2023
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2023
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Human Chorionic Gonadotropin Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2023
6.1. Company market share of key players, 2023
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Human Chorionic Gonadotropin Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Human Chorionic Gonadotropin Market, By Type
8.1. Global Human Chorionic Gonadotropin Market Overview, by Type
8.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By Type, 2023 Vs 2032 (in %)
8.2. Recombinant Human Chorionic Gonadotropin (r-hCG)
8.2.1. Global Human Chorionic Gonadotropin Market, By Recombinant Human Chorionic Gonadotropin (r-hCG), By Region, 2019-2032(US$ Mn)
8.2.2. Market Dynamics for Recombinant Human Chorionic Gonadotropin (r-hCG)
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Urinary Human Chorionic Gonadotropin (u-hCG)
8.3.1. Global Human Chorionic Gonadotropin Market, By Urinary Human Chorionic Gonadotropin (u-hCG), By Region, 2019-2032 (US$ Mn)
8.3.2. Market Dynamics for Urinary Human Chorionic Gonadotropin (u-hCG)
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global Human Chorionic Gonadotropin Market, By Application
9.1. Global Human Chorionic Gonadotropin Market Overview, by Application
9.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By Application, 2023 Vs 2032 (in %)
9.2. Female Infertility Treatment
9.2.1. Global Human Chorionic Gonadotropin Market, By Female Infertility Treatment, By Region, 2019-2032 (US$ Mn)
9.2.2. Market Dynamics for Female Infertility Treatment
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Male Infertility Treatment
9.3.1. Global Human Chorionic Gonadotropin Market, By Male Infertility Treatment, By Region, 2019-2032 (US$ Mn)
9.3.2. Market Dynamics for Male Infertility Treatment
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Ovulation Disorders
9.4.1. Global Human Chorionic Gonadotropin Market, By Ovulation Disorders, By Region, 2019-2032 (US$ Mn)
9.4.2. Market Dynamics for Ovulation Disorders
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Cryptorchidism
9.5.1. Global Human Chorionic Gonadotropin Market, By Cryptorchidism, By Region, 2019-2032 (US$ Mn)
9.5.2. Market Dynamics for Cryptorchidism
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Others
9.6.1. Global Human Chorionic Gonadotropin Market, By Others, By Region, 2019-2032 (US$ Mn)
9.6.2. Market Dynamics for Others
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
10. Global Human Chorionic Gonadotropin Market, By Route of Administration
10.1. Global Human Chorionic Gonadotropin Market Overview, by Route of Administration
10.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By Route of Administration, 2023 Vs 2032 (in %)
10.2. Intramuscular Injection
10.2.1. Global Human Chorionic Gonadotropin Market, By Intramuscular Injection, By Region, 2019-2032 (US$ Mn)
10.2.2. Market Dynamics for Intramuscular Injection
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Subcutaneous Injection
10.3.1. Global Human Chorionic Gonadotropin Market, By Subcutaneous Injection, By Region, 2019-2032 (US$ Mn)
10.3.2. Market Dynamics for Subcutaneous Injection
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Human Chorionic Gonadotropin Market, By End-User
11.1. Global Human Chorionic Gonadotropin Market Overview, by End-User
11.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By End-User, 2023 Vs 2032 (in %)
11.2. Hospitals
11.2.1. Global Human Chorionic Gonadotropin Market, By Hospitals, By Region, 2019-2032 (US$ Mn)
11.2.2. Market Dynamics for Hospitals
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Fertility Clinics
11.3.1. Global Human Chorionic Gonadotropin Market, By Fertility Clinics, By Region, 2019-2032 (US$ Mn)
11.3.2. Market Dynamics for Fertility Clinics
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Research Institutes
11.4.1. Global Human Chorionic Gonadotropin Market, By Research Institutes, By Region, 2019-2032 (US$ Mn)
11.4.2. Market Dynamics for Research Institutes
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Others
11.5.1. Global Human Chorionic Gonadotropin Market, By Others, By Region, 2019-2032 (US$ Mn)
11.5.2. Market Dynamics for Others
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
12. Global Human Chorionic Gonadotropin Market, By Pregnancy Test Kits
12.1. Global Human Chorionic Gonadotropin Market Overview, by Pregnancy Test Kits
12.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By Pregnancy Test Kits, 2023 Vs 2032 (in %)
12.2. Urine-based Pregnancy Test Kits
12.2.1. Global Human Chorionic Gonadotropin Market, By Urine-based Pregnancy Test Kits, By Region, 2019-2032 (US$ Mn)
12.2.2. Market Dynamics for Urine-based Pregnancy Test Kits
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Blood-based Pregnancy Test Kits
12.3.1. Global Human Chorionic Gonadotropin Market, By Blood-based Pregnancy Test Kits, By Region, 2019-2032 (US$ Mn)
12.3.2. Market Dynamics for Blood-based Pregnancy Test Kits
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global Human Chorionic Gonadotropin Market, By Dosage Form
13.1. Global Human Chorionic Gonadotropin Market Overview, by Dosage Form
13.1.1. Global Human Chorionic Gonadotropin Market Revenue Share, By Dosage Form, 2023 Vs 2032 (in %)
13.2. Powder for Injection
13.2.1. Global Human Chorionic Gonadotropin Market, By Powder for Injection, By Region, 2019-2032 (US$ Mn)
13.2.2. Market Dynamics for Powder for Injection
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Liquid for Injection
13.3.1. Global Human Chorionic Gonadotropin Market, By Liquid for Injection, By Region, 2019-2032 (US$ Mn)
13.3.2. Market Dynamics for Liquid for Injection
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global Human Chorionic Gonadotropin Market, By Region
14.1. Global Human Chorionic Gonadotropin Market Overview, by Region
14.1.1. Global Human Chorionic Gonadotropin Market, By Region, 2023 vs 2032 (in%)
14.2. Type
14.2.1. Global Human Chorionic Gonadotropin Market, By Type, 2019-2032 (US$ Mn)
14.3. Application
14.3.1. Global Human Chorionic Gonadotropin Market, By Application, 2019-2032 (US$ Mn)
14.4. Route of Administration
14.4.1. Global Human Chorionic Gonadotropin Market, By Route of Administration, 2019-2032 (US$ Mn)
14.5. End-User
14.5.1. Global Human Chorionic Gonadotropin Market, By End-User, 2019-2032 (US$ Mn)
14.6. Pregnancy Test Kits
14.6.1. Global Human Chorionic Gonadotropin Market, By Pregnancy Test Kits, 2019-2032 (US$ Mn)
14.7. Dosage Form
14.7.1. Global Human Chorionic Gonadotropin Market, By Dosage Form, 2019-2032 (US$ Mn)
15. North America Human Chorionic Gonadotropin Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. North America Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. North America Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. North America Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. North America Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. North America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. North America Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. North America Human Chorionic Gonadotropin Market, by Country, 2019-2032(US$ Mn)
15.8.1. North America Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
15.8.2. U.S.
15.8.3. Canada
15.8.4. Mexico
16. Europe Human Chorionic Gonadotropin Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Europe Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Europe Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Europe Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Europe Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Europe Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Europe Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. Europe Human Chorionic Gonadotropin Market, by Country, 2019-2032 (US$ Mn)
16.8.1. Europe Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
16.8.2. UK
16.8.3. France
16.8.4. Germany
16.8.5. Italy
16.8.6. Spain
16.8.7. Benelux
16.8.8. Russia
16.8.9. Rest of Europe
17. Asia Pacific Human Chorionic Gonadotropin Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Asia Pacific Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Asia Pacific Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Asia Pacific Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Asia Pacific Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Asia Pacific Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Asia Pacific Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Asia Pacific Human Chorionic Gonadotropin Market, by Country, 2019-2032 (US$ Mn)
17.8.1. Asia Pacific Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
17.8.2. China
17.8.3. Japan
17.8.4. India
17.8.5. South Korea
17.8.6. South East Asia
17.8.7. Rest of Asia Pacific
18. Latin America Human Chorionic Gonadotropin Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Latin America Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Latin America Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Latin America Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Latin America Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Latin America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Latin America Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Latin America Human Chorionic Gonadotropin Market, by Country, 2019-2032 (US$ Mn)
18.8.1. Latin America Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
18.8.2. Brazil
18.8.3. Argentina
18.8.4. Rest of Latin America
19. Middle East Human Chorionic Gonadotropin Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Middle East Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Middle East Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Middle East Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Middle East Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Middle East Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Middle East Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Middle East Human Chorionic Gonadotropin Market, by Country, 2019-2032 (US$ Mn)
19.8.1. Middle East Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
19.8.2. UAE
19.8.3. Saudi Arabia
19.8.4. Rest of Middle East
20. Africa Human Chorionic Gonadotropin Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Africa Human Chorionic Gonadotropin Market, by Type, 2019-2032(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Africa Human Chorionic Gonadotropin Market, by Application, 2019-2032(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2032(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Africa Human Chorionic Gonadotropin Market, by End-User, 2019-2032(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2032(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2032(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Africa Human Chorionic Gonadotropin Market, by Country, 2019-2032 (US$ Mn)
20.8.1. Middle East Human Chorionic Gonadotropin Market, by Country, 2023 Vs 2032 (in%)
20.8.2. South Africa
20.8.3. Egypt
20.8.4. Rest of Africa
21. Company Profiles
21.1. Sanzyme
21.1.1. Company Overview
21.1.2. Products/Services Portfolio
21.1.3. Geographical Presence
21.1.4. SWOT Analysis
21.1.5. Financial Summary
21.1.5.1. Market Revenue and Net Profit (2019-2023)
21.1.5.2. Business Segment Revenue Analysis
21.1.5.3. Geographical Revenue Analysis
21.2. Merck & Co. Inc.
21.3. Ferring BV
21.4. Fresenius Kabi AG
21.5. Sun Pharmaceutical Industries Ltd
21.6. Medix Biochemica (Lee BioSolutions Inc.)
21.7. Scripps Laboratories
21.8. Prospec-Tany Technogene Ltd
21.9. Biocare Medical LLC
21.10. Kamiya Biomedical Company
21.11. Others
22. Research Methodology
22.1. Research Methodology
22.2. Phase I – Secondary Research
22.3. Phase II – Data Modelling
22.3.1. Company Share Analysis Model
22.3.2. Revenue Based Modelling
22.4. Phase III – Primary Research
22.5. Research Limitations
22.5.1. Assumptions

List of Figures
FIG. 1 Global Human Chorionic Gonadotropin Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Human Chorionic Gonadotropin Market Segmentation
FIG. 4 Global Human Chorionic Gonadotropin Market, by Type, 2023 (US$ Mn)
FIG. 5 Global Human Chorionic Gonadotropin Market, by Application, 2023 (US$ Mn)
FIG. 6 Global Human Chorionic Gonadotropin Market, by Route of Administration, 2023 (US$ Mn)
FIG. 7 Global Human Chorionic Gonadotropin Market, by End-User, 2023 (US$ Mn)
FIG. 8 Global Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2023 (US$ Mn)
FIG. 9 Global Human Chorionic Gonadotropin Market, by Dosage Form, 2023 (US$ Mn)
FIG. 10 Global Human Chorionic Gonadotropin Market, by Geography, 2023 (US$ Mn)
FIG. 11 Attractive Investment Proposition, by Type, 2023
FIG. 12 Attractive Investment Proposition, by Application, 2023
FIG. 13 Attractive Investment Proposition, by Route of Administration, 2023
FIG. 14 Attractive Investment Proposition, by End-User, 2023
FIG. 15 Attractive Investment Proposition, by Pregnancy Test Kits, 2023
FIG. 16 Attractive Investment Proposition, by Dosage Form, 2023
FIG. 17 Attractive Investment Proposition, by Geography, 2023
FIG. 18 Global Market Share Analysis of Key Human Chorionic Gonadotropin Market Manufacturers, 2023
FIG. 19 Global Market Positioning of Key Human Chorionic Gonadotropin Market Manufacturers, 2023
FIG. 20 Global Human Chorionic Gonadotropin Market Value Contribution, By Type, 2023&2032 (Value %)
FIG. 21 Global Human Chorionic Gonadotropin Market, by Recombinant Human Chorionic Gonadotropin (r-hCG), By Region, 2019-2023 (US$ Mn)
FIG. 22 Global Human Chorionic Gonadotropin Market, by Urinary Human Chorionic Gonadotropin (u-hCG), By Region, 2019-2023 (US$ Mn)
FIG. 23 Global Human Chorionic Gonadotropin Market Value Contribution, By Application, 2023&2032 (Value %)
FIG. 24 Global Human Chorionic Gonadotropin Market, by Female Infertility Treatment, By Region, 2019-2023 (US$ Mn)
FIG. 25 Global Human Chorionic Gonadotropin Market, by Male Infertility Treatment, By Region, 2019-2023 (US$ Mn)
FIG. 26 Global Human Chorionic Gonadotropin Market, by Ovulation Disorders, By Region, 2019-2023 (US$ Mn)
FIG. 27 Global Human Chorionic Gonadotropin Market, by Cryptorchidism, By Region, 2019-2023 (US$ Mn)
FIG. 28 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
FIG. 29 Global Human Chorionic Gonadotropin Market Value Contribution, By Route of Administration, 2023&2032 (Value %)
FIG. 30 Global Human Chorionic Gonadotropin Market, by Intramuscular Injection, By Region, 2019-2023 (US$ Mn)
FIG. 31 Global Human Chorionic Gonadotropin Market, by Subcutaneous Injection, By Region, 2019-2023 (US$ Mn)
FIG. 32 Global Human Chorionic Gonadotropin Market Value Contribution, By End-User, 2023&2032 (Value %)
FIG. 33 Global Human Chorionic Gonadotropin Market, by Hospitals, By Region, 2019-2023 (US$ Mn)
FIG. 34 Global Human Chorionic Gonadotropin Market, by Fertility Clinics, By Region, 2019-2023 (US$ Mn)
FIG. 35 Global Human Chorionic Gonadotropin Market, by Research Institutes, By Region, 2019-2023 (US$ Mn)
FIG. 36 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
FIG. 37 Global Human Chorionic Gonadotropin Market Value Contribution, By Pregnancy Test Kits, 2023&2032 (Value %)
FIG. 38 Global Human Chorionic Gonadotropin Market, by Urine-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
FIG. 39 Global Human Chorionic Gonadotropin Market, by Blood-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
FIG. 40 Global Human Chorionic Gonadotropin Market Value Contribution, By Dosage Form, 2023&2032 (Value %)
FIG. 41 Global Human Chorionic Gonadotropin Market, by Powder for Injection, By Region, 2019-2023 (US$ Mn)
FIG. 42 Global Human Chorionic Gonadotropin Market, by Liquid for Injection, By Region, 2019-2023 (US$ Mn)
FIG. 43 North America Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 44 U.S. Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 45 Canada Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 46 Mexico Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 47 Europe Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 48 Germany Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 49 France Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 50 U.K. Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 51 Italy Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 52 Spain Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 53 Benelux Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 54 Russia Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 55 Rest of Europe Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 56 Asia Pacific Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 57 China Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 58 Japan Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 59 India Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 60 South Korea Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 61 South-East Asia Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 62 Rest of Asia Pacific Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 63 Latin America Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 64 Brazil Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 65 Argentina Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 66 Rest of Latin America Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 67 Middle East Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 68 UAE Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 69 Saudi Arabia Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 70 Rest of Middle East Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 71 Africa Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 72 South Africa Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 73 Egypt Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)
FIG. 74 Rest of Africa Human Chorionic Gonadotropin Market, 2019-2032 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Human Chorionic Gonadotropin Market
TABLE 2 Global Human Chorionic Gonadotropin Market: Market Drivers Impact Analysis
TABLE 3 Global Human Chorionic Gonadotropin Market: Market Restraints Impact Analysis
TABLE 4 Global Human Chorionic Gonadotropin Market, by Competitive Benchmarking, 2023
TABLE 5 Global Human Chorionic Gonadotropin Market, by Geographical Presence Analysis, 2023
TABLE 6 Global Human Chorionic Gonadotropin Market, by Key Strategies Analysis, 2023
TABLE 7 Global Human Chorionic Gonadotropin Market, by Recombinant Human Chorionic Gonadotropin (r-hCG), By Region, 2019-2023 (US$ Mn)
TABLE 8 Global Human Chorionic Gonadotropin Market, by Recombinant Human Chorionic Gonadotropin (r-hCG), By Region, 2024-2032 (US$ Mn)
TABLE 9 Global Human Chorionic Gonadotropin Market, by Urinary Human Chorionic Gonadotropin (u-hCG), By Region, 2019-2023 (US$ Mn)
TABLE 10 Global Human Chorionic Gonadotropin Market, by Urinary Human Chorionic Gonadotropin (u-hCG), By Region, 2019-2023 (US$ Mn)
TABLE 11 Global Human Chorionic Gonadotropin Market, by Female Infertility Treatment, By Region, 2019-2023 (US$ Mn)
TABLE 12 Global Human Chorionic Gonadotropin Market, by Female Infertility Treatment, By Region, 2019-2023 (US$ Mn)
TABLE 13 Global Human Chorionic Gonadotropin Market, by Male Infertility Treatment, By Region, 2019-2023 (US$ Mn)
TABLE 14 Global Human Chorionic Gonadotropin Market, by Male Infertility Treatment, By Region, 2019-2023 (US$ Mn)
TABLE 15 Global Human Chorionic Gonadotropin Market, by Ovulation Disorders, By Region, 2019-2023 (US$ Mn)
TABLE 16 Global Human Chorionic Gonadotropin Market, by Ovulation Disorders, By Region, 2019-2023 (US$ Mn)
TABLE 17 Global Human Chorionic Gonadotropin Market, by Cryptorchidism, By Region, 2019-2023 (US$ Mn)
TABLE 18 Global Human Chorionic Gonadotropin Market, by Cryptorchidism, By Region, 2019-2023 (US$ Mn)
TABLE 19 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 20 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 21 Global Human Chorionic Gonadotropin Market, by Intramuscular Injection, By Region, 2019-2023 (US$ Mn)
TABLE 22 Global Human Chorionic Gonadotropin Market, by Intramuscular Injection, By Region, 2019-2023 (US$ Mn)
TABLE 23 Global Human Chorionic Gonadotropin Market, by Subcutaneous Injection, By Region, 2019-2023 (US$ Mn)
TABLE 24 Global Human Chorionic Gonadotropin Market, by Subcutaneous Injection, By Region, 2019-2023 (US$ Mn)
TABLE 25 Global Human Chorionic Gonadotropin Market, by Hospitals, By Region, 2019-2023 (US$ Mn)
TABLE 26 Global Human Chorionic Gonadotropin Market, by Hospitals, By Region, 2019-2023 (US$ Mn)
TABLE 27 Global Human Chorionic Gonadotropin Market, by Fertility Clinics, By Region, 2019-2023 (US$ Mn)
TABLE 28 Global Human Chorionic Gonadotropin Market, by Fertility Clinics, By Region, 2019-2023 (US$ Mn)
TABLE 29 Global Human Chorionic Gonadotropin Market, by Research Institutes, By Region, 2019-2023 (US$ Mn)
TABLE 30 Global Human Chorionic Gonadotropin Market, by Research Institutes, By Region, 2019-2023 (US$ Mn)
TABLE 31 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 32 Global Human Chorionic Gonadotropin Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 33 Global Human Chorionic Gonadotropin Market, by Urine-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
TABLE 34 Global Human Chorionic Gonadotropin Market, by Urine-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
TABLE 35 Global Human Chorionic Gonadotropin Market, by Blood-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
TABLE 36 Global Human Chorionic Gonadotropin Market, by Blood-based Pregnancy Test Kits, By Region, 2019-2023 (US$ Mn)
TABLE 37 Global Human Chorionic Gonadotropin Market, by Powder for Injection, By Region, 2019-2023 (US$ Mn)
TABLE 38 Global Human Chorionic Gonadotropin Market, by Powder for Injection, By Region, 2019-2023 (US$ Mn)
TABLE 39 Global Human Chorionic Gonadotropin Market, by Liquid for Injection, By Region, 2019-2023 (US$ Mn)
TABLE 40 Global Human Chorionic Gonadotropin Market, by Liquid for Injection, By Region, 2019-2023 (US$ Mn)
TABLE 41 Global Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 42 Global Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 43 Global Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 44 Global Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 45 Global Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 46 Global Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 47 Global Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 48 Global Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 49 Global Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 50 Global Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 51 Global Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 52 Global Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 53 Global Human Chorionic Gonadotropin Market, by Region, 2019-2023 (US$ Mn)
TABLE 54 Global Human Chorionic Gonadotropin Market, by Region, 2024-2032 (US$ Mn)
TABLE 55 North America Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 56 North America Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 57 North America Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 58 North America Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 59 North America Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 60 North America Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 61 North America Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 62 North America Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 63 North America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 64 North America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 65 North America Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 66 North America Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 67 North America Human Chorionic Gonadotropin Market, by Country, 2019-2023 (US$ Mn)
TABLE 68 North America Human Chorionic Gonadotropin Market, by Country, 2024-2032 (US$ Mn)
TABLE 69 United States Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 70 United States Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 71 United States Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 72 United States Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 73 United States Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 74 United States Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 75 United States Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 76 United States Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 77 United States Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 78 United States Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 79 United States Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 80 United States Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)

TABLE 81 Canada Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 82 Canada Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 83 Canada Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 84 Canada Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 85 Canada Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 86 Canada Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 87 Canada Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 88 Canada Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 89 Canada ca Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 90 Canada Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 91 Canada Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 92 Canada Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 93 Mexico Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 94 Mexico Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 95 Mexico Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 96 Mexico Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 97 Mexico Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 98 Mexico Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 99 Mexico Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 100 Mexico Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 101 Mexico Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 102 Mexico Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 103 Mexico Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 104 Mexico Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 105 Europe Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 106 Europe Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 107 Europe Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 108 Europe Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 109 Europe Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 110 Europe Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 111 Europe Human Chorionic Gonadotropin Market, by Country, 2019-2023 (US$ Mn)
TABLE 112 Europe Human Chorionic Gonadotropin Market, by Country, 2024-2032 (US$ Mn)
TABLE 113 Europe Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 114 Europe Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 115 Europe Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 116 Europe Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 117 Europe Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 118 Europe Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 119 Germany Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 120 Germany Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 121 Germany Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 122 Germany Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 123 Germany Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 124 Germany Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 125 Germany Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 126 Germany Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 127 Germany Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 128 Germany Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 129 Germany Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 130 France Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 131 France Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 132 France Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 133 France Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 134 France Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 135 France Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 136 France Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 137 France Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 138 France Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 139 France Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 140 France Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 141 France Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 142 United Kingdom Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 143 United Kingdom Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 144 United Kingdom Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 145 United Kingdom Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 146 United Kingdom Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 147 United Kingdom Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 148 United Kingdom Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 149 United Kingdom Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 150 United Kingdom Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 151 United Kingdom Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 152 United Kingdom Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 153 United Kingdom Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 154 Italy Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 155 Italy Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 156 Italy Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 157 Italy Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 158 Italy Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 159 Italy Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 160 Italy Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 161 Italy Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 162 Italy Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 163 Italy Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 164 Italy Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 165 Italy Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 166 Spain Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 167 Spain Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 168 Spain Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 169 Spain Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 170 Spain Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 171 Spain Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 172 Spain Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 173 Spain Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 174 Spain Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 175 Spain Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 176 Spain Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 177 Spain Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 178 Benelux Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 179 Benelux Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 180 Benelux Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 181 Benelux Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 182 Benelux Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 183 Benelux Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 184 Benelux Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 185 Benelux Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 186 Benelux Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 187 Benelux Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 188 Benelux Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 189 Benelux Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 190 Russia Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 191 Russia Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 192 Russia Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 193 Russia Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 194 Russia Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 195 Russia Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 196 Russia Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 197 Russia Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 198 Russia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 199 Russia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 200 Russia Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 201 Russia Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 202 Rest of Europe Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 203 Rest of Europe Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 204 Rest of Europe Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 205 Rest of Europe Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 206 Rest of Europe Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 207 Rest of Europe Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 208 Rest of Europe Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 209 Rest of Europe Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 210 Rest of Europe Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 211 Rest of Europe Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 212 Rest of Europe Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 213 Rest of Europe Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 214 Asia Pacific Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 215 Asia Pacific Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 216 Asia Pacific Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 217 Asia Pacific Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 218 Asia Pacific Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 219 Asia Pacific Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 220 Asia Pacific Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 221 Asia Pacific Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 222 Asia Pacific Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 223 Asia Pacific Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 224 Asia Pacific Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 225 Asia Pacific Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 226 China Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 227 China Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 228 China Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 229 China Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 230 China Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 231 China Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 232 China Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 233 China Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 234 China Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 235 China Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 236 China Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 237 China Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 238 Japan Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 239 Japan Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 240 Japan Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 241 Japan Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 242 Japan Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 243 Japan Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 244 Japan Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 245 Japan Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 246 Japan Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 247 Japan Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 248 Japan Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 249 Japan Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 250 India Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 251 India Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 252 India Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 253 India Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 254 India Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 255 India Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 256 India Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 257 India Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 258 India Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 259 India Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 260 India Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 261 India Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 262 South Korea Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 263 South Korea Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 264 South Korea Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 265 South Korea Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 266 South Korea Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 267 South Korea Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 268 South Korea Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 269 South Korea Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 270 South Korea Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 271 South Korea Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 272 South Korea Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 273 South Korea Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 274 South-East Asia Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 275 South-East Asia Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 276 South-East Asia Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 277 South-East Asia Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 278 South-East Asia Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 279 South-East Asia Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 280 South-East Asia Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 281 South-East Asia Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 282 South-East Asia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 283 South-East Asia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 284 South-East Asia a Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 285 South-East Asia Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)

TABLE 286 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 287 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 288 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 289 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 290 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 291 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 292 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 293 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 294 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 295 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 296 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 297 Rest of Asia Pacific Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 298 Latin America Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 299 Latin America Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 300 Latin America Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 301 Latin America Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 302 Latin America Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 303 Latin America Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 304 Latin America Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 305 Latin America Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 306 Latin America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 307 Latin America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 308 Latin America Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 309 Latin America Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 310 Brazil Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 311 Brazil Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 312 Brazil Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 313 Brazil Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 314 Brazil Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 315 Brazil Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 316 Brazil Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 317 Brazil Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 318 Brazil Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 319 Brazil Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 320 Brazil Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 321 Brazil Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 322 Argentina Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 323 Argentina Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 324 Argentina Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 325 Argentina Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 326 Argentina Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 327 Argentina Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 328 Argentina Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 329 Argentina Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 330 Argentina Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 331 Argentina Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 332 Argentina Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 333 Argentina Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 334 Rest of Latin America Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 335 Rest of Latin America Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 336 Rest of Latin America Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 337 Rest of Latin America Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 338 Rest of Latin America Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 339 Rest of Latin America Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 340 Rest of Latin America Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 341 Rest of Latin America Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 342 Rest of Latin America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 343 Rest of Latin America Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 344 Rest of Latin America Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 345 Rest of Latin America Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)

TABLE 346 Middle East Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 347 Middle East Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 348 Middle East Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 349 Middle East Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 350 Middle East Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 351 Middle East Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 352 Middle East Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 353 Middle East Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 354 Middle East rica Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 355 Middle East Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 356 Middle East Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 357 Middle East Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 358 UAE Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 359 UAE Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 360 UAE Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 361 UAE Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 362 UAE Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 363 UAE Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 364 UAE Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 365 UAE Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 366 UAE Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 367 UAE Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 368 UAE Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 369 UAE Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 370 Saudi Arabia Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 371 Saudi Arabia Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 372 Saudi Arabia Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 373 Saudi Arabia Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 374 Saudi Arabia Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 375 Saudi Arabia Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 376 Saudi Arabia Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 377 Saudi Arabia Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 378 Saudi Arabia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 379 Saudi Arabia Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 380 Saudi Arabia Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 381 Saudi Arabia Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 382 Rest of Middle East Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 383 Rest of Middle East Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 384 Rest of Middle East Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 385 Rest of Middle East Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 386 Rest of Middle East Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 387 Rest of Middle East Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 388 Rest of Middle East Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 389 Rest of Middle East Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 390 Rest of Middle East Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 391 Rest of Middle East Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 392 Rest of Middle East Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 393 Rest of Middle East Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 394 Africa Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 395 Africa Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 396 Africa Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 397 Africa Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 398 Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 399 Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 400 Africa Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 401 Africa Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 402 Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 403 Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 404 Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 405 Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)

TABLE 406 South Africa Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 407 South Africa Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 408 South Africa Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 409 South Africa Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 410 South Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 411 South Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 412 South Africa Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 413 South Africa Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 414 South Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 415 South Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 416 South Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 417 South Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 418 Egypt Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 419 Egypt Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 420 Egypt Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 421 Egypt Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 422 Egypt Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 423 Egypt Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 424 Egypt Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 425 Egypt Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 426 Egypt Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 427 Egypt Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 428 Egypt Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 429 Egypt Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)
TABLE 430 Rest of Africa Human Chorionic Gonadotropin Market, by Type, 2019-2023 (US$ Mn)
TABLE 431 Rest of Africa Human Chorionic Gonadotropin Market, by Type, 2024-2032 (US$ Mn)
TABLE 432 Rest of Africa Human Chorionic Gonadotropin Market, by Application, 2019-2023 (US$ Mn)
TABLE 433 Rest of Africa Human Chorionic Gonadotropin Market, by Application, 2024-2032 (US$ Mn)
TABLE 434 Rest of Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2019-2023 (US$ Mn)
TABLE 435 Rest of Africa Human Chorionic Gonadotropin Market, by Route of Administration, 2024-2032 (US$ Mn)
TABLE 436 Rest of Africa Human Chorionic Gonadotropin Market, by End-User, 2019-2023 (US$ Mn)
TABLE 437 Rest of Africa Human Chorionic Gonadotropin Market, by End-User, 2024-2032 (US$ Mn)
TABLE 438 Rest of Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2019-2023 (US$ Mn)
TABLE 439 Rest of Africa Human Chorionic Gonadotropin Market, by Pregnancy Test Kits, 2024-2032 (US$ Mn)
TABLE 440 Rest of Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2019-2023 (US$ Mn)
TABLE 441 Rest of Africa Human Chorionic Gonadotropin Market, by Dosage Form, 2024-2032 (US$ Mn)

Frequently Asked Questions:

What is the current size of the global Human Chorionic Gonadotropin market?

The global Human Chorionic Gonadotropin market was valued at USD 1151.5 million in 2023.

What is the expected growth rate of the Human Chorionic Gonadotropin market between 2024 and 2032?

The Human Chorionic Gonadotropin market is expected to grow at a CAGR of 8.10% between 2024 and 2032, reaching USD 2321.11 Million in 2032.

Which segment is leading the market share in terms of Type?

In the Human Chorionic Gonadotropin Market, the segment leading in terms of Type is the Recombinant Human Chorionic Gonadotropin (r-hCG). This segment holds a dominant market share, accounting for 60-65%.

Which Application segment governs the demand for Human Chorionic Gonadotropin in the world?

The application segment that governs the demand for Human Chorionic Gonadotropin worldwide is the Female Infertility Treatment segment. This particular application holds the largest share, accounting for approximately 35-40% of the market. The demand for Human Chorionic Gonadotropin in female infertility treatment is driven by factors such as the rising prevalence of female infertility issues, including ovulation disorders and Polycystic Ovary Syndrome (PCOS).

Which End-User segment is expected to post the highest CAGR during the forecast period?

During the forecast period, the End-User segment expected to post the highest Compound Annual Growth Rate (CAGR) in the Human Chorionic Gonadotropin Market is the Fertility Clinics.

Cancer Profiling Market

Published:
Report ID: 36289

Flowable Hemostats Market

Published:
Report ID: 36279

Fibrin Sealants Market

Published:
Report ID: 36276

Prostate Cancer Market

Published:
Report ID: 36273

ECG Telemetry Devices Market

Published:
Report ID: 36237

Blotting Systems Market

Published:
Report ID: 36233

India Dental Consumables Market

Published:
Report ID: 36214

Biotechnology and Pharmaceutical Services Outsourcing Market

Published:
Report ID: 36191

India Bariatric Surgery Devices Market

Published:
Report ID: 36164

Veterinary Imaging Systems Market

Published:
Report ID: 36104

Bioprosthetics Market

Published:
Report ID: 36087

Antineoplastic Agents Market

Published:
Report ID: 36065

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN